About ActoGeniX
ActoGeniX is a company based in Ghent (Belgium) founded in 2006 was acquired by Precigen in February 2015. ActoGeniX has raised $57.24 million across 4 funding rounds from investors including Gimv, VIB and Precigen. ActoGeniX operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
- Headquarter Ghent, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ActoGeniX
ActoGeniX has successfully raised a total of $57.24M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $14.04 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ActoGeniX
ActoGeniX has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Gimv, VIB and Precigen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private equity firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ActoGeniX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ActoGeniX
Investment portfolio details for ActoGeniX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ActoGeniX
Detailed financials for ActoGeniX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actogenix Comparisons
Peer comparison for ActoGeniX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ActoGeniX
ActoGeniX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
Detailed competitors of ActoGeniX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actogenix
Complete news archive for ActoGeniX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ActoGeniX
ActoGeniX was founded in 2006 and raised its 1st funding round 1 year after it was founded.
ActoGeniX is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
ActoGeniX is a funded company, having raised a total of $57.24M across 4 funding rounds to date.
ActoGeniX was founded in 2006 in Ghent, Belgium, within the biotechnology sector. Operations center on the TopAct platform, by which food-grade microbes are modified to produce ActoBiotics, orally administered biopharmaceuticals that express cytokines, enzymes, and antibodies locally in the gastrointestinal tract. Clinical products address oral mucositis and inflammatory bowel disease. The company was acquired by Intrexon Corp. in February 2015.
ActoGeniX has 9 investors. Key investors include Gimv, VIB, Precigen, Life Sciences Partners, and Saffelberg Investments.